Overview

Drug Interaction Study With RV521 in Healthy Volunteer Subjects

Status:
Completed
Trial end date:
2019-03-17
Target enrollment:
Participant gender:
Summary
The main aim of this study is to determine whether RV521 interacts with any other medication using four licensed medicines (midazolam, itraconazole, rifampicin and verapamil) that are known to have specific effects on enzymes and transporter proteins that influence the absorption of drugs
Phase:
Phase 1
Details
Lead Sponsor:
ReViral Ltd
Treatments:
Hydroxyitraconazole
Itraconazole
Midazolam
Rifampin
Verapamil